Apo-Nifed en es it fr

Apo-Nifed Brand names, Apo-Nifed Analogs

Apo-Nifed Brand Names Mixture

  • No information avaliable

Apo-Nifed Chemical_Formula


Apo-Nifed RX_link


Apo-Nifed fda sheet

Apo-Nifed FDA

Apo-Nifed msds (material safety sheet)

Apo-Nifed MSDS

Apo-Nifed Synthesis Reference

Bossert, Vater, U.S. Pat. 3,485,847 (1969)

Apo-Nifed Molecular Weight

346.335 g/mol

Apo-Nifed Melting Point

172 - 174 oC

Apo-Nifed H2O Solubility


Apo-Nifed State


Apo-Nifed LogP


Apo-Nifed Dosage Forms

Capsule; Tablet; Tablet (extended-release)

Apo-Nifed Indication

For the management of vasospastic angina, chronic stable angina and hypertension.

Apo-Nifed Pharmacology

Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Apo-Nifed Absorption

Rapidly and fully absorbed following oral administration.

Apo-Nifed side effects and Toxicity

Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)

Apo-Nifed Patient Information

Apo-Nifed Organisms Affected

Humans and other mammals